Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-06 Sale | 2022-04-08 4:21 pm | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $65 | $112,320 | 8,002 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 4:31 pm | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $57.49 | $49,675 | 9,730 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 8:38 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher CHIEF OPERATING OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-17 4:19 pm | N/A 2033-02-15 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-04-06 Exercise | 2022-04-08 4:21 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $16 | 8,002 (Direct) | View |
| 2022-04-06 Exercise | 2022-04-08 4:21 pm | N/A 2030-04-07 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 1,728 | $0 | 8,002 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:31 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $16 | 9,730 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:31 pm | N/A 2030-04-07 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 864 | $0 | 9,730 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:45 pm | N/A 2032-01-31 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2022-02-03 4:37 pm | N/A 2029-09-18 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 0 | $0 | 32,898 (Direct) | View |